QUANTUM GENOMICS Stock Euronext Paris
Equities
FR0011648971
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.97M 7.58M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.26M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.7M 9.46M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.11
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - |
1st Jan change | Capi. | |
---|---|---|
+23.50% | 47.07B | |
+47.19% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |